Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908

  1. Dunkel, I.J.
  2. Doz, F.
  3. Foreman, N.K.
  4. Hargrave, D.
  5. Lassaletta, A.
  6. Andres, N.
  7. Hansford, J.R.
  8. Hassall, T.
  9. Eyrich, M.
  10. Gururangan, S.
  11. Bartels, U.
  12. Gajjar, A.
  13. Howell, L.
  14. Warad, D.
  15. Pacius, M.
  16. Tam, R.
  17. Wang, Y.
  18. Zhu, L.
  19. Cohen, K.
Revue:
Neuro-Oncology

ISSN: 1523-5866,  1522-8517

Année de publication: 2023

Volumen: 25

Número: 8

Pages: 1530-1545

Type: Article

DOI: 10.1093/NEUONC/NOAD031 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus